Država: Združene države Amerike
Jezik: angleščina
Source: NLM (National Library of Medicine)
AZATHIOPRINE (UNII: MRK240IY2L) (AZATHIOPRINE - UNII:MRK240IY2L)
Zydus Lifesciences Limited
AZATHIOPRINE
AZATHIOPRINE 50 mg
ORAL
PRESCRIPTION DRUG
Azathioprine tablets, USP are indicated as an adjunct for the prevention of rejection in renal homotransplantation. It is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. Azathioprine tablets, USP are indicated as an adjunct for the prevention of rejection in renal homotransplantation. Experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for HLA antigens, anti-donor or anti-B-cell alloantigen antibody, and other variables. The effect of azathioprine tablets on these variables has not been tested in controlled trials. Azathioprine tablets, USP are indicated for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms. Aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with azathioprine tablets. The combined use of azathioprine tablets with disease modifying anti-rheumatic drugs (DMARDs) has not been studied for
Azathioprine Tablets USP, 50 mg are yellow, round, flat, beveled edge tablets with bisect on one side; one side of the bisect is debossed with logo of "ZC" and other side is debossed with "59" and other side is plain and are supplied as follows: NDC 65841-602-01 in bottles of 100 tablets NDC 65841-602-05 in bottles of 500 tablets Store at 20° to 25° C (68° to 77° F) [See USP Controlled Room Temperature] in a dry place and protect from light. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Abbreviated New Drug Application
AZATHIOPRINE - AZATHIOPRINE TABLET ZYDUS LIFESCIENCES LIMITED ---------- AZATHIOPRINE TABLETS, USP PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-602-01 in bottle of 100 tablets Azathioprine Tablets USP, 50 mg 100 tablets Rx only AZATHIOPRINE azathioprine tablet PRODUCT INFORMATION PRODUCT TYPE HUMAN PRESCRIPTION DRUG ITEM CODE (SOURCE) NDC:65841-602 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH AZATHIOPRINE (UNII: MRK240IY2L) (AZATHIOPRINE - UNII:MRK240IY2L) AZ ATHIOPRINE 50 mg Zydus Lifesciences Limited INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) MAGNESIUM STEARATE (UNII: 70097M6I30) POVIDONE (UNII: FZ989GH94E) STARCH, CORN (UNII: O8232NY3SJ) PRODUCT CHARACTERISTICS COLOR YELLOW (YELLOW) SCORE 2 pieces SHAPE ROUND (ROUND) SIZE 8mm FLAVOR IMPRINT CODE Z C;59 CONTAINS PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:65841-602- 01 100 in 1 BOTTLE; Type 0: Not a Combination Product 07/11/2007 2 NDC:65841-602- 05 500 in 1 BOTTLE; Type 0: Not a Combination Product 07/11/2007 MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE ANDA ANDA077621 07/11/2007 LABELER - Zydus Lifesciences Limited (918596198) REGISTRANT - Zydus Lifesciences Limited (918596198) ESTABLISHMENT NAME ADDRESS ID/FEI BUSINESS OPERATIONS Zydus Lifesciences Limited 918596198 ANALYSIS(65841-602) , MANUFACTURE(65841-602) Revised: 8/2022 Preberite celoten dokument